BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 15, 2005
View Archived Issues
Antisoma updates pipeline progress
Read More
FDA extends Yaz oral contraceptive NDA review period
Read More
Sinovac Biotech receives government funding for pandemic vaccine development
Read More
Novartis and Ono sign Japanese agreement for rivastigmine transdermal patch
Read More
Vanda begins phase III study of iloperidone for schizophrenia
Read More
IMPACT I study of OvaRex for ovarian cancer completes enrollment
Read More
Enhanced cytotoxicity provided by new humanized anti-CD30 MAb
Read More
Preclinical profile of a novel phenyl-substituted cannabinoid presented
Read More
Therapeutic potential of Syk inhibitors from Rigel for cancer and hematological disease
Read More
CNTO-1275 modulates CLA via IL-12 in the treatment of psoriasis
Read More
LRRK2 protein identified as a potential target for the treatment of Parkinson's disease
Read More
Efficacy and minimal toxicity of pralatrexate in patients with drug-resistant T-cell lymphoma
Read More
Recent patents reveal new immunomodulators
Read More
Iplex approved for severe primary IGF-1 deficiency
Read More
New therapeutic agents for skin disorders disclosed
Read More
U.K. clearance for phase III study of CA4P in NSCLC
Read More
Xechem acquires rights to five-membered heterocyclic antisickling compound
Read More
Go-ahead for phase II study of Prochymal in Crohn's disease
Read More
Novel antiinfective agents patented
Read More
ViRexx Medical files CTA for phase I study of HepaVaxx B
Read More
New phase I studies for ALN-RSV01 for RSV
Read More
GSK to develop Vertex's VX-409 for treatment of pain
Read More
Roche files IND for Genmab collaborative antibody
Read More
GSK selects new development candidate from Cytokinetics collaboration
Read More
Radius acquires rights to Ipsen's BA-058 for osteoporosis
Read More
Phase II findings with XRP-6258 encouraging in metastatic breast cancer
Read More
SU-11248 active in patients with refractory metastatic breast cancer
Read More
AG-013736 safe when combined with docetaxel in metastatic breast cancer patients
Read More
Lapatinib assessed in phase I and II breast cancer studies
Read More